Search Login Register

JM 3100 Summary

Description: a bicyclam derivate, highly potent & selective inhibitor of HIV-1 & HIV-2; partial structure given in first source

Also Known As: 1,1'-(1,4-phenylenebis(methylene))bis(1,4,8,11-tetraazacyclotetradecane)octahydrochloride dihydrate; 1,1'-(1,4-phenylenebis-(methylene))-bis-1,4,8,11-tetraazacyclotetradecane octahydrochloride dihydrate; AMD 3100; AMD 3329; AMD-3100 Show All >>

Networked: 458 relevant articles (61 outcomes, 77 trials/studies) for this Drug

Key Diseases for which JM 3100 is Relevant

  1. Neoplasms (Cancer) : 15 outcomes 10 studies in 91 results
  2. Multiple Myeloma : 13 outcomes 24 studies in 95 results
  3. Non-Hodgkin Lymphoma (Lymphosarcoma) : 10 outcomes 19 studies in 68 results
  4. Lymphoma (Lymphomas) : 7 outcomes 9 studies in 42 results
  5. Hodgkin Disease (Hodgkin's Disease) : 5 outcomes 5 studies in 20 results
Show All >>

Drugs Related to JM 3100

  1. Granulocyte Colony-Stimulating Factor (G-CSF)
  2. JM 3100
  3. Chemokine CXCL12
  4. CXCR4 Receptors (CXCR4 Receptor)
  5. Cyclophosphamide (Cytoxan)
  6. rituximab (Mabthera)
  7. docetaxel (Taxotere)
  8. Bleomycin (Blenoxane)
  9. sunitinib (Sutent)
  10. Hydroxyurea (Hydrea)
Show All >>

Therapies Related to JM 3100

  1. Blood Component Removal (Apheresis)
  2. Hematopoietic Stem Cell Mobilization
  3. Transplantation (Transplant Recipients)
  4. Drug Therapy (Chemotherapy)
  5. Transplants (Transplant)
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.